Decreased Prevalence of Chlamydia trachomatis Infection Associated With a Selective Screening Program in Family Planning Clinics in Wisconsin

Addiss, David G.; Vaughn, Michael; Ludka, Deborah; Pfister, John; Davis, Jeffrey P.

doi:10.1097/00007435-199301000-00006

Cited by 97 publications

(45 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Use of a barrier method was shown to be associated with reduced risk of infection compared with the use of other methods of contraception in two of five studies in females (33,54,70,71,87). Compared with no contraceptives, use of a barrier method was protective against chlamydia for females in three of five studies (32,69,81,88,89). Only one of 10 studies found female barrier users to be significantly less likely to be infected than female nonusers (37,55,79,(90)(91)(92)(93)(94)(95)(96).…”

Section: Risk Factors For Genital Chlamydial Infectionmentioning

confidence: 97%

“…Users of OCP may also be less likely to use barrier contraceptives. OCP users tend to have higher prevalences of infection compared with nonusers, but this association is not significant after adjusting for other variables in the majority of studies reviewed (24,32,33,51,55,56,72,81,87,(90)(91)(92)94,95,103,104). Only two studies found that oral contraceptive users were significantly more likely to have chlamydia than nonusers after controlling for other risk factors (69,79), while Mosure et al (89) found that OCP users had a 20% decreased risk of being infected with chlamydia compared with females who did not use any method of contraception.…”

Section: Risk Factors For Genital Chlamydial Infectionmentioning

confidence: 98%

“…In their study, cervical ectopy was correlated significantly with use of OCP, while chlamydial infection was related strongly to ectopy, regardless of contraceptive practice. However, while eight of 10 studies examining this risk factor found that women with cervical ectopy were more likely to be infected with C trachomatis (32,55,70,72,81,94,96,103), only two of those studies showed this relationship to be significant after adjusting for other variables (55,94).…”

Section: Risk Factors For Genital Chlamydial Infectionmentioning

confidence: 98%

“…This pattern has been demonstrated in areas where chlamydia control programs have been in place for a year or more. In all five studies set in populations with well-established screening programs, reporting recent multiple partnerships was significantly associated with a 1.2 to 2.2-fold increase in risk in multivariate analysis (24,68,69,81,82). In three of those studies, reporting having a new partner was significant before adjusting for other variables (68,81,82), and in Mosure et al's (69) study, published in 1996, this variable was significant in multivariate analysis (OR 1.7, 95% CI 1.5 to 1.9).…”

Section: Number and Type Of Partnersmentioning

confidence: 99%

See 3 more Smart Citations

Risk factors for genital chlamydial infection

Navarro

Jolly²,

Nair³

et al. 2003

J Sex Reprod Med

View full text Add to dashboard Cite

OBJECTIVE:To discuss the occurrence of genital chlamydia in developed countries and review the literature assessing the potential risk factors for this sexually transmitted disease. DATA SOURCES: A MEDLINE search was performed for all English citations from 1985 to 2000 that contain the keywords "Chlamydia trachomatis", "chlamydial infections", "risk factors" and "sex behaviour". All relevant references cited in articles that were obtained from the search were also included. DATA EXTRACTION: All articles obtained from the above sources were examined, and were included in the review if they met the following criteria: primary study examining sociodemographic or behavioural risk factors associated with genital chlamydial infection using multivariate analysis; study subjects 12 years of age and older; and study setting in a developed country. DATA SYNTHESIS AND CONCLUSIONS:Genital chlamydial infection has become the most commonly reported bacterial infection in North America over the past decade. Thirty-eight cross-sectional studies and six cohort studies were included in the present review. Most studies demonstrated that young men and women are at higher risk of being infected with chlamydia than older subjects. Chlamydia seems to be found in a diverse group of people, and unlike gonorrhea, is not concentrated in low income, minority core groups with high rates of partner change. However, a number of studies have shown that communities with well-established control programs are beginning to demonstrate this pattern. There is no clear evidence that chlamydia is associated with type of partners, contraceptive use, or age at first intercourse. Future research should follow this sexually transmitted disease as it evolves through the epidemiological stages to ensure that preventive and treatment services are reaching those people who are most likely to be infected.

show abstract

Section: Risk Factors For Genital Chlamydial Infectionmentioning

confidence: 97%

Section: Risk Factors For Genital Chlamydial Infectionmentioning

confidence: 98%

Section: Risk Factors For Genital Chlamydial Infectionmentioning

confidence: 98%

Section: Number and Type Of Partnersmentioning

confidence: 99%

See 2 more Smart Citations

Risk factors for genital chlamydial infection

Navarro

Jolly²,

Nair³

et al. 2003

J Sex Reprod Med

View full text Add to dashboard Cite

show abstract

“…22,53 Experience in Sweden and the USA, and pilot studies in the UK 60 and The Netherlands, 68 show that this approach is feasible. Ecological associations between falling rates of chlamydia and its complications in Sweden 56,57,69,70 and the USA 71,72 during the 1990s have been widely cited as evidence of the effectiveness of opportunistic screening. [73][74][75] This interpretation ignores evidence that the fall in pelvic inflammatory disease in Sweden began before any chlamydia control activities were introduced.…”

Section: Criteria For Establishing a Screening Programmementioning

confidence: 99%

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection

Low

McCarthy²,

Macleod³

et al. 2007

Health Technol Assess

133

181

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as r...

show abstract